Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Li

Showing results (101-110 of 155) with videos related to

Pageof 16
Sort By:
Allergy and Asthma Proceedings|December 10, 2016
Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedemaMarc A Riedl, William R Lumry, H Henry Li, et al.
The Journal of Clinical Investigation|January 22, 2026
Dermal fibroblasts respond to interleukin-4 and 13 and promote T-cell recruitment in atopic dermatitisTomofumi Numata, Michael Shia, Yoshiyuki Nakamura, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 8, 2025
Hereditary Angioedema With Normal C1 Inhibitor: A Quarter Century of Forward Progress and Persisting ObstaclesSandra C Christiansen, Aleena Banerji, Jonathan A Bernstein, et al.
Allergy and Asthma Proceedings|May 16, 2015
Current state of hereditary angioedema management: a patient surveyAleena Banerji, Paula Busse, Sandra C Christiansen, et al.
Advances in Therapy|May 20, 2026
Post Hoc Analysis of Recombinant C1 Inhibitor Clinical Data Using Contemporary Endpoints for Hereditary AngioedemaMarc A Riedl, Nihal Narsipur, Douglas Jones, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 29, 2014
Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trialMarc A Riedl, Jonathan A Bernstein, Henry Li, et al.
The New England Journal of Medicine|October 6, 2006
Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitisPeter S Creticos, John T Schroeder, Robert G Hamilton, et al.
CJEM|February 7, 2025
Establishing methodological standards for the development of artificial intelligence-based Clinical Decision Support in emergency medicineHashim Kareemi, Henry Li, Akshay Rajaram, et al.
Allergy and Asthma Proceedings|March 15, 2013
Efficacy and safety of ecallantide in treatment of recurrent attacks of hereditary angioedema: open-label continuation studyWilliam R Lumry, Jonathan A Bernstein, H Henry Li, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 8, 2016
Subcutaneous Icatibant for the Treatment of Hereditary Angioedema Attacks: Comparison of Home Self-Administration with Administration at a Medical FacilityIris M Otani, William R Lumry, Shelley Hurwitz, et al.
Pageof 16

Showing results (101-110 of 155) with videos related to

Sort By:
Pageof 16
Allergy and Asthma Proceedings|December 10, 2016
Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedemaMarc A Riedl, William R Lumry, H Henry Li, et al.
The Journal of Clinical Investigation|January 22, 2026
Dermal fibroblasts respond to interleukin-4 and 13 and promote T-cell recruitment in atopic dermatitisTomofumi Numata, Michael Shia, Yoshiyuki Nakamura, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 8, 2025
Hereditary Angioedema With Normal C1 Inhibitor: A Quarter Century of Forward Progress and Persisting ObstaclesSandra C Christiansen, Aleena Banerji, Jonathan A Bernstein, et al.
Allergy and Asthma Proceedings|May 16, 2015
Current state of hereditary angioedema management: a patient surveyAleena Banerji, Paula Busse, Sandra C Christiansen, et al.
Advances in Therapy|May 20, 2026
Post Hoc Analysis of Recombinant C1 Inhibitor Clinical Data Using Contemporary Endpoints for Hereditary AngioedemaMarc A Riedl, Nihal Narsipur, Douglas Jones, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 29, 2014
Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trialMarc A Riedl, Jonathan A Bernstein, Henry Li, et al.
The New England Journal of Medicine|October 6, 2006
Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitisPeter S Creticos, John T Schroeder, Robert G Hamilton, et al.
CJEM|February 7, 2025
Establishing methodological standards for the development of artificial intelligence-based Clinical Decision Support in emergency medicineHashim Kareemi, Henry Li, Akshay Rajaram, et al.
Allergy and Asthma Proceedings|March 15, 2013
Efficacy and safety of ecallantide in treatment of recurrent attacks of hereditary angioedema: open-label continuation studyWilliam R Lumry, Jonathan A Bernstein, H Henry Li, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 8, 2016
Subcutaneous Icatibant for the Treatment of Hereditary Angioedema Attacks: Comparison of Home Self-Administration with Administration at a Medical FacilityIris M Otani, William R Lumry, Shelley Hurwitz, et al.
Pageof 16